middle.news
Paradigm Sets Stage for PARA_OA_012 Phase 3 Results
9:01am on Wednesday 23rd of September, 2026 AEST
•
Biotechnology and Pharmaceuticals
Read Story
Paradigm Sets Stage for PARA_OA_012 Phase 3 Results
9:01am on Wednesday 23rd of September, 2026 AEST
Key Points
PAR and PAROB suspended from quotation from 23 September
Suspension pending PARA_OA_012 Phase 3 interim analysis results
Company requested the suspension to manage continuous disclosure obligations
Trading could resume on 28 September, subject to ASX agreement
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Paradigm Biopharmaceuticals (ASX:PAR)
OPEN ARTICLE